Below are the most recent publications written about "Placenta Accreta" by people in Profiles.
-
Suarez S, Conde-Agudelo A, Borovac-Pinheiro A, Suarez-Rebling D, Eckardt M, Theron G, Burke TF. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020 04; 222(4):293.e1-293.e52.
-
Mulla BM, Weatherford R, Redhunt AM, Modest AM, Hacker MR, Hecht JL, Spiel MH, Shainker SA. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. Arch Gynecol Obstet. 2019 12; 300(6):1601-1606.
-
Carusi DA. The Placenta Accreta Spectrum: Epidemiology and Risk Factors. Clin Obstet Gynecol. 2018 12; 61(4):733-742.
-
Sannananja B, Ellermeier A, Hippe DS, Winter TC, Kang SK, Lee SI, Kilgore MR, Dighe MK. Utility of diffusion-weighted MR imaging in the diagnosis of placenta accreta spectrum abnormality. Abdom Radiol (NY). 2018 11; 43(11):3147-3156.
-
Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. Anesth Analg. 2018 10; 127(4):930-938.
-
Parra MW, Ordoñez CA, Herrera-Escobar JP, Gonzalez-Garcia A, Guben J. Resuscitative endovascular balloon occlusion of the aorta for placenta percreta/previa. J Trauma Acute Care Surg. 2018 02; 84(2):403-405.
-
Alanwar A, Al-Sayed HM, Ibrahim AM, Elkotb AM, Abdelshafy A, Abdelhadi R, Abbas AM, Abdelmenam HS, Fares T, Nossair W, Abdallah AA, Sabaa H, Nawara M. Urinary tract injuries during cesarean section in patients with morbid placental adherence: retrospective cohort study. J Matern Fetal Neonatal Med. 2019 May; 32(9):1461-1467.
-
Picel AC, Wolford B, Cochran RL, Ramos GA, Roberts AC. Prophylactic Internal Iliac Artery Occlusion Balloon Placement to Reduce Operative Blood Loss in Patients with Invasive Placenta. J Vasc Interv Radiol. 2018 02; 29(2):219-224.
-
Perlman NC, Little SE, Thomas A, Cantonwine DE, Carusi DA. Timing surgery for previa-accreta: patient selection based on a priori risk factors. Acta Obstet Gynecol Scand. 2017 08; 96(8):1030.
-
Shainker SA, Dannheim K, Gerson KD, Neo D, Zsengeller ZK, Pernicone E, Karumanchi SA, Hacker MR, Hecht JL. Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation. Arch Gynecol Obstet. 2017 Aug; 296(2):257-262.